Graduate Theses, Dissertations, and Problem Reports
2022

Evaluating the Feasibility of a Collaborative Care Clinical Pathway
for the Treatment of Adolescent Depression and Anxiety in Rural
Pediatric Primary Care
Kayla R. Watson
West Virginia University, kayla.watson@hsc.wvu.edu

Follow this and additional works at: https://researchrepository.wvu.edu/etd
Part of the Pediatric Nursing Commons

Recommended Citation
Watson, Kayla R., "Evaluating the Feasibility of a Collaborative Care Clinical Pathway for the Treatment of
Adolescent Depression and Anxiety in Rural Pediatric Primary Care" (2022). Graduate Theses,
Dissertations, and Problem Reports. 11635.
https://researchrepository.wvu.edu/etd/11635

This Problem/Project Report is protected by copyright and/or related rights. It has been brought to you by the The
Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Problem/Project
Report in any way that is permitted by the copyright and related rights legislation that applies to your use. For other
uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a
Creative Commons license in the record and/ or on the work itself. This Problem/Project Report has been accepted
for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized
administrator of The Research Repository @ WVU. For more information, please contact
researchrepository@mail.wvu.edu.

Evaluating the Feasibility of a Collaborative Care Clinical Pathway for the Treatment of
Adolescent Depression and Anxiety in Rural Pediatric Primary Care
Kayla Watson
DNP Project Manuscript submitted
to the School of Nursing
at West Virginia University

in partial fulfillment of the requirements for the degree of
Doctor of Nursing Practice
Suzy Walter, PhD, APRN, FNP-BC, CNRN, Chair
Lauren W. M. Swager, M.D.

Morgantown, WV
2022

Keywords: Pediatrics, adolescent depression, adolescent anxiety, collaborative care models,
primary care, rural pediatrics
Copyright 2022

ABSTRACT
Evaluating the Feasibility of a Collaborative Care Clinical Pathway for the Treatment of
Adolescent Depression and Anxiety in Rural Pediatric Primary Care
Kayla Watson
Background: Due to a national shortage of Child and Adolescent Psychiatrists (CAP), Primary
Care Providers (PCP) are often required to manage patients with mental health disorders despite
a lack of focused training and lower self-efficacy or confidence in the management of these
disorders. Referral to CAPs for management following the diagnosis of adolescent depression
and anxiety is a common practice. The integration of mental health services within the primary
care setting can overcome many of these barriers and have been shown to improve patient
outcomes. This model involves PCPs prescribing psychotherapeutic drugs while the patient
receives evidence-based psychotherapies provided by community Behavioral Health Clinicians
(BHC).
Purpose: The purpose of this quality improvement (QI) project is to incorporate evidenced-based
practice recommendations and select components from integrated care models (ICM) to design a
collaborative care, decision making pathway for PCPs to utilize in the management of adolescent
depression and anxiety and to evaluate the feasibility of the intervention within the primary care
practice setting.
Methods: A literature review and synthesis was completed to gather current recommendations
and determine the most effective components of ICMs. A collaborative clinical decision-making
pathway was designed and presented to the project participants in the form of a PCP packet
containing a medication guide, a treatment algorithm, a BHC provider directory, and a list of
built in EMR visit and patient handout templates for clinical use. A focus group was held with
project participants following a 12- week implementation period to determine the feasibility of
the project. Focus group data were evaluated by coding responses and identifying common
themes relating to feasibility. Future directions of the project were also discussed. Preimplementation and post self-efficacy mean scores on a modified version of the Mental Illness
Management (MIM) questionnaire were calculated as a secondary outcome measure.
Results: The clinical decision-making pathway was determined to be feasible within the intended
practice setting based on the feasibility areas of emphasis: acceptability and demand. Mean
scores of the MIM questionnaire showed a positive trend for each of the survey items suggesting
the intended effect on care delivery.
Discussion: This QI initiative met each project aim through successful implementation and by an
increase in provided collaborative care, an increase in the level of integration within the practice
setting, a positive trend in PCP self-efficacy following implementation, and a decrease in the
time from diagnosis- to- treatment of adolescent depression and anxiety. Following the
determination of intervention feasibility, further testing within the organization is recommended
and warranted.
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Introduction and Background
Problem Description
Despite a growing mental health crisis, there is a severe shortage of practicing Child and
Adolescent Psychiatrists (CAP) in the United States (American Academy of Child & Adolescent
Psychiatry, 2022). CAPs have specialized training to deliver both psychotherapies, medications,
or a combination of both, to children and adolescents with a variety of mental health diagnoses.
Due to this shortage, Primary Care Providers (PCP) must often assume the responsibility for
management of child and adolescent mental health disorders. However, approximately two thirds
of PCPs practicing in pediatric primary care feel inadequately trained in mental health care
treatment (Center for Disease Control and Prevention, 2021). Decreased PCP self-efficacy or
confidence in the management of mental health illnesses, is associated with a higher likelihood
of referral to psychiatry, increasing the time between diagnosis and treatment initiation due to the
shortage of CAPs (Peterson et al., 2018). Common reasons that PCPs transfer care to a CAP or a
BHC rather than assuming management or co-management of behavioral health disorders
include; lack of formal training, decreased confidence, time constraints, and reimbursement
challenges (Walter et al., 2021).
When primary care providers report lower confidence or self-efficacy in treatment of a
behavioral health disorder, they are less likely to assume management of the condition. This
leads to referral to a specialist (Peterson et al., 2018; Walter et al., 2019, 2021). Patients are often
placed on waitlists and receive no care between the time of referral and when services with the
CAP or BHC begin. Additionally, patient engagement and follow through is often an issue after
referrals to CAPs and BHCs. According to Petts & Shahidullah (2020), patients face structural
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and perceptual barriers to seeking and receiving mental health services. Cited barriers include
stigma, insurance coverage, geographic distances, attitudes about services, and discomfort
receiving mental health services. When untreated, behavioral health disorders result in negative
health outcomes including a higher incidence of suicide, accidental injuries, risky sexual
behaviors, and unplanned pregnancy (Richardson, et al., 2017). Incorporation of mental health
services into pediatric primary care has the potential to mitigate these secondary risks.
Data from the National Institute of Mental Health (NIMH) indicate that the prevalence of
at least one depressive episode is 13.3% in adolescents aged 12-17 years. Additionally, 71 % of
those adolescents experienced severe impairment and roughly 60% received no treatment.
Additionally, 2.4% received medication only, without a CAP or other behavioral health clinician
(BHC) involvement in the patient’s care plan (National Institute of Mental Health, 2019). Data
from The National Comorbidity Survey–Adolescent Supplement (NCS-A) suggest that the
lifetime prevalence of anxiety is estimated to be 20-30% of the population (Merikangas et al.,
2010). The prevalence of mental health disorders is compounded by the coronavirus-19
pandemic presumably due to increased fear associated with the disease and social mitigation
strategies (Czeisler, 2020).
The Treatment for Adolescents with Depression Study (TADS), funded by NIMH and
described in the publication by March, et al. (2007), concluded that combination therapy, with
medication and psychotherapy, is about twice as effective in the treatment of adolescent mental
health disorders as those interventions alone. The possible increase in suicidal ideation and
suicidal events in adolescents is a major barrier to provider confidence in choosing SSRIs to treat
adolescents with both depression and anxiety. The TADS study data suggest that combination
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therapy with a SSRI and cognitive behavioral therapy (CBT), may be protective against suicidal
events in adolescents with depression (March et al., 2007).
According to published practice guidelines, combination therapy is considered the gold
standard treatment for pediatric anxiety and depression (Cheung et al., 2018; Walter et al., 2019).
Collaboration between PCPs and BHCs is an alternative way to deliver combination therapy to
patients with mild to moderate anxiety and/or depression when there is not an available CAP.
This format involves the PCP making regular contact with the patient and prescribing
psychopharmacology when appropriate. Concurrently, the BHC provides evidence- based
psychotherapy. Ideally, the PCP also has a relationship with a CAP that assures availability for
consultation and referral should initial primary care management fail. The term integrated care
model (ICM) refers to the delivery of behavioral and mental healthcare within the primary care
setting (Asarnow, et al. 2015).
In 2019, the ratio of CAPs to the number of children <18 in West Virginia (WV) was
10:100,000 (as cited in American Academy of Child & Adolescent Psychiatry, 2022). Further
contributing to this deficit is that not all CAPs practicing in the state accept Medicaid or
Children’s Health Insurance Program (CHIP) insurance which are the insurance carriers that
cover approximately 50% of WV children.
The PCPs participating in this Doctor of Nursing Practice (DNP) project use referral,
with the intention to transfer care for anxiety and depression, as a common practice. The referralto- service time with a CAP in this project’s setting, is approximately six to eight months.
Consequently, waitlists to receive evidence-based psychotherapies by BHCs have increased to
around three to four months. In response, some of the PCPs proceed to prescribe
psychopharmacotherapy for certain patients, while others are uncomfortable starting medications
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without the evaluation of a psychiatrist. Even when pharmacotherapeutic treatment for
depression and anxiety is initiated, there is no routine protocol for mental health follow up
appointments with the PCP. Across the three affiliated pediatric practices included in this
project, there is no consistent practice protocol for managing adolescent anxiety and depression.
This leads to inconsistent treatment regimens, fragmented care, poor communication between
PCPs and community BHC referral sites, and lack of treatment for the pediatric patients
diagnosed with anxiety, depression, or both.
Use of integrated care models (ICM), to incorporate mental healthcare within primary
care settings, is a proposed solution to this practice problem. It is also theorized that practice
tools such as algorithms or clinical pathways can increase PCP likelihood to manage mental
health disorders (Peterson et al., 2018). The pediatric-specific clinical practice guideline by
Zuckerbrot, et. al (2018), contains a recommendation for the use of decision-making tools for
PCPs to aid in providing standardized care, as well as improved coordination of care across
health providers in the treatment of adolescent depression.
Project Aims
The purpose of this quality improvement (QI) project is to incorporate evidence-based
practice recommendations and components of integrated care models to develop and evaluate the
feasibility of a collaborative care clinical pathway. The pathway will aid in PCP clinical decision
making, for the treatment of adolescent depression and anxiety, in the pediatric primary care
setting. The project aims are as follows:
1. Implement the use of a designed clinical pathway in the pediatric primary care
setting.
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2. Increase collaboration between participating PCPs and the community BHCs with
shared patients.
3. Improve provider self-efficacy in the treatment of adolescent depression and
anxiety using the clinical pathway.
4. Reduce the time from diagnosis- to- treatment of adolescent depression and
anxiety.
Literature Review and Synthesis
Search Strategy
To explore the existence, effectiveness, and components of integrated care models in the
treatment of pediatric depression and/or anxiety and to develop a clinical practice pathway for
treatment decision making, the following PICO(T) question was developed: In adolescents with
diagnosed depression, anxiety, or both (P), will the utilization of components of integrated or
collaborative care models in pediatric primary care (I), compared to usual care or waitlisted
status after referral, improve mental health care delivered by pediatric primary care
providers(O)?
A comprehensive search of CINAHL with full text, PUBMED, Ebscohost, Medline, and
Google Scholar was conducted from January to July 2021 guided by the PICO(T) question.
Searches were limited to publication in the last 10 years and to the English language. Examples
of keywords include “integrated mental health care”, “pediatrics”, “primary care”, “adolescent”,
“behavioral health”, “integrated behavioral health care models”, “treatment models”, “protocol”,
“anxiety”, and “depression”. A total of 156 abstracts were screened for inclusion/ exclusion
criteria (See Appendix A for literature search matrix).
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Articles were retained for review if the study population included pediatric patients aged
10-18; a collaborative or co-located behavioral health professional was utilized; the study took
place in the primary care setting; and if an integrated care model was used in the treatment of
depression, anxiety, or other mental health disorder. After the application of inclusion and
exclusion criteria, four articles were selected for review and full text manuscripts were obtained.
An additional manuscript was found through the snowballing method as it was cited in several
retained articles. Relevant clinical practice guidelines were reviewed for both adolescent anxiety
and depression to compare current recommendations to the strength of evidence in the literature.
The pediatric primary care- specific anxiety guideline is described in the publication by Walter,
et al. (2020). The two- part clinical practice guideline for the management of depression in
pediatric primary care is described in the publications by Cheung et al., (2018) and Zuckerbrot et
al. (2018).
Available Knowledge
This literature review encompasses two clinical practice guidelines, two systematic
reviews, one metanalysis, and one implementation study. The Agree II tool was used to critically
appraise the clinical practice guidelines (Brouwers et al., 2010). The rapid critical appraisal tool
published by Fineout-Overholt & Melnyk (2005) was utilized to explore the rigor of the
systematic reviews and the metanalysis. A synthesis table was created for ease of comparison
across studies (see Appendix B).
Clinical Practice Guidelines
Clinical practice guidelines by Cheung et al. (2018), Zuckerbrot et al. (2018), and Walter
et al. (2020) unanimously emphasize the pediatric primary care clinician’s role as the first line
provider in the diagnosis and management of adolescent depression and anxiety. These
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publications suggest that integrated care has no standard definition and that the level of
integration depends on multiple factors such as office space, resources, and personnel. Walter et
al. (2020) acknowledges that collaborative care would conserve CAPs and psychiatric mental
health nurse practitioners for severe presentations, thereby decreasing the referral-to-service gap.
A suggested model would involve PCPs initiating and managing psychopharmacology while
remaining active in care delivery via scheduled follow up appointments and BHCs administering
adjunct psychotherapy for those with mild or moderate presentations (Walter et al., 2020).
The clinical practice guidelines for pediatric anxiety and depression acknowledge the
shortage of CAPs as an urgent health care problem. Additionally, these publications suggest that
use of ICMs has the potential to shorten the time between diagnoses and treatment. The
guidelines by Zuckerbrot et al. (2018) and Walter et al. (2020) have recommendations and
dosages for medications to treat these conditions and recommend that the patient receive some
type of evidence-based psychotherapy administered by a BHC if possible. These guidelines also
acknowledge that there is growing evidence that collaborative care improves patient
symptomology and functionality (Walter et al., 2020; Zuckerbrot et al., 2018).
Evidence Supporting Integrated Care Models
Asarnow et al. (2015) completed a systematic meta-analysis with the purpose of
determining if the use of ICMs leads to improvement of patient access to behavioral health care,
enhances patient outcomes, and increases cost effectiveness of care compared to standard or
enhanced primary care. The authors claim to be the first to cross-study the effectiveness of ICMs
in the pediatric population and is cited in all articles selected in this literature synthesis. The
authors broadly defined integrated behavioral healthcare as the inclusion of mental healthcare
within the primary care setting. Enhanced usual care, a commonly used control condition,
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involved use of an educational program for providers, without any components of integrated or
collaborative care. Integrated care can be further classified as being collaborative, co-located, or
fully integrated (The Center for Integrated Health Solutions, n.d).
It was concluded in this meta-analysis that ICMs with collaborative care had the most
positive impact on patient outcomes including symptoms and functionality. Those studies with
the most statistically significant results involved collaborative care using evidence-based
medication algorithms and other clinical decision-making tools, adjunct psychotherapy, and a
shared care plan with a mental health specialist. The recommendation of this meta-analysis calls
for an increase in research on the effectiveness of ICMs especially as it pertains to treatment of
targeted patient populations (Asarnow et al., 2015).
A systematic review by Burkhart, et al. (2020) explored the application of various types
of ICMs and the associated increase in access to mental healthcare, patient satisfaction, and
symptom improvement. Type of study, number and characteristics of study participants,
assessment tools used to measure outcomes, ICM type, and care team participants were
compared across studies. All studies reported a positive correlation between intervention (ICM
or collaborative protocols) and measured outcomes. These models of care were compared to
usual or enhanced usual care. The author emphasizes that use of ICMs provides the benefits of
increased treatment initiation and completion suggesting an increase access to mental healthcare.
(Burkhart et al., 2020).
A longitudinal, 5- year study on the development and implementation of the Behavioral
Health Integration Program (BHIP), a type of ICM, was conducted by Walter et al. (2019). The
program was implemented across 71 practices within a single healthcare system. Components of
the program included a behavioral health training program for a PCP selected as the practice
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champion, consultation via telephone for those with mild to moderate presentations, and an innetwork referral system for those with severe presentations. The Behavioral Health Integration
Readiness Assessment (BHIRA), which assigns a score based on the level of behavioral health
integration, was used to collect data prior to implementation of the program and was repeated
following program completion for comparison. The researchers also evaluated patient
symptomology, patient access and experiences with the care provided, health care provider
satisfaction and self-efficacy, and patient visit costs across the organization (Walter et al., 2019).
At the conclusion of the 5-year project described in Walter et al. (2019), behavioral
health visits increased in primary care settings, but not in the specialty care settings. This
suggests that access to mental health care increased during that time. Patients’ visit costs in the
outpatient setting increased by 8%, but emergency behavioral visit costs decreased by 19%.
Additionally, over 90% of PCP survey responses indicated satisfaction with self-efficacy in the
treatment of mild and moderate anxiety, depression, and other behavioral health disorders. The
study concluded that the BHIP, even in the practices with lower BHIRA scores upon program
completion, increased access to care and provision of services, and had the potential to decrease
stigma, enhance patient outcomes, and decrease overall healthcare costs (Walter et al., 2019).
The systematic review by Yonek et al. (2020) selected 11 randomized control trials and
compared key components across existing pediatric integrated models to identify which portions
are associated with statistically significant, positive correlations between ICM components and
patient outcomes. Improvement in clinical symptomology, using various measurement-based
tools, was the primary outcome evaluated in each study. Examples of secondary outcomes
evaluated were patient functionality, internalization of symptoms, patient satisfaction, and
completion of the patient’s therapy course.
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The analysis by Yonek et al. (2020) demonstrated that components embedded in the
ICMs that were concluded to have the most supportive evidence were population-based care,
measurement-based care, and evidence-based mental health services. Population-based care
involves initiatives to identify all patients with a disease, initiate management, and track
outcomes. Measurement-based care involves using validated tools to identify patients with
mental health conditions and to monitor treatment response. Evidence-based mental health
services involve referral to BHCs for psychotherapy and PCP managed pharmacotherapy. All
three of these components were present in seven randomized controlled trials with statistically
significant positive correlations between intervention and symptom improvement (Yonek et al.,
2020).
Other components that have shown efficacy include psychiatric consultation, team-based
care using a care manager to assist with care coordination between health professionals, and
shared treatment plans between PCPs and BHCs. This review by Yonek et al., (2020) is unique
in nature as the authors studied individual ICM components while previous publications only
evaluated ICMs as a “packaged” practice model. The results of this systematic review would
allow individual organizations or practices to build a custom ICM using the individual elements
that best fit their specific patient population and may prove useful in rural settings where
resources are less readily available.
Literature Synthesis
General findings across studies suggest that the implementation of an ICM is associated
with an increase in access to care, cost-effectiveness and reduction, provider self-efficacy and
satisfaction, improvement in patient symptoms and functionality and enhanced patient
satisfaction. The ability to implement existing ICMs or components of ICMs varies by patient
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population and clinical site. CCMs are defined as a type of ICM in the literature primarily in
cases where PCPs and BHCs practice is separate facilities.
Currently, many PCPs are tasked with the responsibility of treating mental health
disorders despite feeling inadequately prepared. Evidence suggests that an integrated or
collaborative approach to treating mental health conditions in pediatric primary care would
improve access to evidence-based treatments for adolescent depression and anxiety. Multiple
studies included in this review recommend the adoption of educational sessions for PCPs, the use
of clinical decision-making tools, and collaboration with community BHCs to facilitate mental
health care integration into primary care.
Theoretical Framework
The Model for Improvement, developed by Associates in Process Improvement, is the
framework that will be used to guide this quality improvement (QI) project. Setting aims,
establishing measures, selecting changes, and testing changes with the Plan, Do, Study, Act
(PDSA) cycle are major components of the model. The Institute for Healthcare Improvement
(n.d.), describes the PDSA as a resource for developing, implementing, studying, and improving
processes. The Plan phase of the PDSA process involves identifying the problem, designing a
change to implement, and determining what outcome or outcomes are desired and how they will
be collected (Institute for Healthcare Improvement, n.d.).
Next in the PDSA cycle is the Do phase. Issues or unanticipated outcomes will be
monitored during this phase and will be addressed when the process recycles. Project challenges
are formally documented for review during the next plan phase of the project. (Institute for
Healthcare Improvement, n.d.)
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During the Study phase, the correlation between the intervention and the desired
outcomes will be analyzed. The significance of the results will be calculated. The data will be
compared to the expected outcomes, critical reflection will take place, and a summary of the
initiative will be reviewed (Institute for Healthcare Improvement, n.d.).
The Act phase of the PDSA process involves adjusting the initiative as needed (CCM,
2021). This is an opportunity to adjust what portions of the practice change did not work well or
as expected and address barriers to full implementation. Once adjustments are made and the
process is improved, the cycle can repeat until the process results in the desired outcomes.
Methods
Context
The setting of this DNP project serves pediatric patients primarily from the underserved,
rural WV counties of Harrison, Ritchie, Marion, Taylor, Lewis, Preston, and Doddridge. One
PCP participant practices in an affiliated clinic located in Monongalia County which serves a
mix of metropolitan and non -metropolitan residents. The rest of the project participants practice
in Harrison County. According to data from the 2019 US Census, as cited by the American
Academy of Child & Adolescent Psychiatry (n.d.), most of these counties have no practicing
CAPs. Harrison county currently has two practicing CAPs, associated with an outside facility,
with a current waitlist time of over one year.
Table 1
WV County data: CAP Practicing in the Project Setting
County

CAPs

Number of Children <18

Shortage Classification

Monongalia

12

17,286

Mostly Sufficient Supply

Harrison

2

14,546

Severe Shortage

13

Taylor

0

3,424

No CAPs

Marion

0

11,289

No CAPs

Lewis

0

3,428

No CAPs

Doddridge

0

1,342

No CAPs

Ritchie

0

1,954

No CAPs

Preston

0

6,510

No CAPs

Note. Adapted from “Workforce maps by state” by the American Academy of Child &
Adolescent Psychiatry. Copyright 2022 by the American Academy of Child & Adolescent
Psychiatry.
Not all of the CAPs practicing in the area of this project’s setting accept Medicaid and/or
CHIP leading to a significant health disparity for this rural WV pediatric population. In- network
CAPS are available through the West Virginia University Hospital (WVU Medicine) health
system located in Monongalia County, WV for psychiatric consultation and referral.
Referral-to-service time with a CAP in the project’s clinical settings is approximately 6 to
8 months. The PCPs that participated in this DNP project include three Pediatric Nurse
Practitioners and four Pediatricians across three pediatric practices. The QI plan for this project
involves developing and exploring the feasibility of an evidence-based, clinical pathway to be
used as a decision-making tool for PCPs managing adolescent depression and anxiety in the rural
WV, pediatric primary care setting.
Intervention
Plan Phase
A clinical pathway for the treatment of adolescent depression and anxiety, designed to
guide PCP clinical decision making, was developed by the project champion using the
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combination of the clinical practice guidelines by Cheung et al., (2018), Walter et, al. (2020) and
Zuckerbrot et al., (2018) and select components of ICMs.
The ICM components incorporated into this clinical pathway included psychiatric
consultation, measurement-based care, evidence-based mental health services, shared planned
communications/ shared treatment plans, and health information technology as cited in Asarnow,
et al. (2015), Burkhart, et al. (2020), Walter et al. (2019), and Yonek, et al. (2020). Table 2 of
this paper contains definitions of each of the components (Yonek, et al., 2020). Components
were selected based on resources that are available to the practice sites but are not formally or
consistently used in the treatment of adolescent depression and anxiety.
Table 2
Integrated Mental Health Care Model Components
Collaborative Care
Model Component
Psychiatric Consultation

Measurement-based care
Evidence- based mental health
services

Planned communications/
shared treatment plans

Definition
A consultation comprises the following:
 Provides guidance directly to the PCP or a care
manager regarding initial treatment plan or patients
who are not adequately responding to treatment,
especially medication therapy
 Conducts occasional in-person or remote video
sessions with selected patients; and
 Provide referrals to specialty care for patients with
complex situations
Use of validated tools to identify patients with a particular
mental health condition and assess treatment response.
Services include the following:
 Brief psychological interventions (eg. Cognitivebehavioral therapy, motivational interviewing,
behavioral activation, or problem-solving treatment)
 Psychotropic prescribing (by the PCP);
 Patient self-management/psychoeducation; and
 Referrals to specialty care (CAPs or BHCs) for
patients with complex situations
 Behavioral health care professionals and PCPs
worked collaboratively in fully or partly integrated
system

15



Care plans developed jointly by behavioral health
clinicians and PCP and accessible to both
professionals
Health Information Technology
 Electronic exchange of protected health information
Note. Adapted from “Key Components of Effective Pediatric Integrated Mental Health Care
Models” by J. Yonek, 2020, Jama Pediatrics, 174(5), p.487-498. Copyright 2020 by the
American Medical Association.
A benchmark for improving this practice problem involves incorporating the highest
level of integrated care according to the framework created by the Center for Health Integration
Solutions (CHIS) (n.d.). However, the baseline state of practice would only allow for an
improvement from level 1 to a level 2 of integrated services. This is because a level 2 is the
highest level that can be achieved in offices without on-site BHCs. Thus, an aim for the first
cycle of the continual quality improvement initiative was to meet the level 2 criteria designated
by the SAMSHA/ HRSA framework. Consideration of these integration levels was utilized in the
design of the intervention (See Appendix C).
A BHC directory was developed to provide a resource of consultants to guide clinicians
in the decision-making process and was provided within the PCP Packet provided to the project
participants. A list of community BHCs with contact information and physical office address was
created and imbedded in the EMR so it could be auto populated by the PCP and printed for the
patients as needed. To compose the BHC directory, a preliminary list of area BHCs was
provided by a nurse practitioner colleague practicing within the Behavioral Health Department
affiliated with the larger hospital system, WVU Medicine. This directory delineates BHCs by
service type, office location, and insurances accepted to aid the PCPs in the referral process.
Alignment with the WVU Medicine Mission and Vision
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Mission: To improve the health of West Virginians and all we serve through excellence
in patient care, research, and education.
Vision: To transform lives and eliminate health disparities through a nationally
recognized patient-centered system of care that includes:


An expanded regional healthcare delivery system



Consistent, integrated patient care recognized for delivering the right care in the right
place at the right time at all sites



Development of new approaches to improve healthcare, including team-based models of
care, expanding WVU clinical and translational research



Educational programs throughout the network recognized for training uniquely qualified
healthcare team members and leaders



A culture of performance and excellence throughout the network
The mission and vision of the organization aligns with the project purpose to improve the

care of West Virginians, eliminate health disparities, and to improve team-based models of
care. Care integration is specifically mentioned in the mission statement (WVU Medicine,
n.d.).
Do Phase
Prior to implementation, an introduction and presentation of the clinical pathway was
delivered to the PCP participants. Baseline data were collected on provider self-efficacy, via the
MIM questionnaire, in the treatment of mental health disorders (see project evaluation). Use of
the clinical pathway was at the discretion of the provider based on individual patient cases,
following the diagnosis of adolescent anxiety and/or depression. Elements of the clinical
pathway were built into smart phrases within the Electronic Health Record (EHR). Smart
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phrases allow the providers to auto populate certain documentation and patient education
materials to aid in following the pathway.
The clinical decision-making pathway consists of a decision-making algorithm, a
directory of community BHCs that administer psychotherapy, a list of designed visit templates
and patient handouts embedded in the electronic health record (EHR) and a psychotherapeutic
medication guide. Additionally, recommended patient follow-up visits with the PCP were
incorporated into the decision-making algorithm of the clinical pathway to encourage adherence
to the treatment plan. The algorithm is based on disease severity and the chosen treatment
course (See Appendix D for the contents of the clinical pathway).
An overarching goal for this project was to begin a continual quality improvement
initiative, including a plan to recycle the process after an initial 12-week implementation period.
A feasibility study was designed to determine if the intervention is relevant and worth further
evaluation within the organizational context. According to the publication by Bowen, et al.
(2009), feasibility studies are useful in determining if a program or intervention is worth more
comprehensive testing to determine efficacy.
Budget
The financial burden of this project was minimal. Extra personnel were not required, and
billing practices did not change. The project formalized and improved existing processes with
the intention to facilitate collaboration with community resources. The DNP candidate served as
the project champion free of cost during the project timeframe.
Project Evaluation Plan
Project Objectives
This QI project has two main objectives:
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1. Examine the feasibility, specifically the acceptability and the demand, of the designed
clinical pathway.
2. Improve the participating PCP’s perceived self-efficacy in the treatment of adolescent
depression and anxiety with the use of the developed clinical pathway.
Study Phase
During the study phase of the PDSA process, a focus group was held to gather qualitative
data on the feasibility of the project. The focus group session was led by the project champion
and guided by ten open-ended questions based on the acceptability and demand areas of focus.
Acceptability explores how the project participants reacted to the intervention. The demand was
evaluated by obtaining data on the estimated or actual use of the intervention in the project
setting. (See Appendix E for the questions used to guide the focus group). Specific outcomes of
interest that were explored during the focus group session are actual use, relevance to practice,
impact on practice, encountered barriers, intent to continue use. (Bowen et al, 2009). Six project
participants attended the focus group and were given the opportunity to discuss the use of the
clinical pathway and determine if the pathway had the intended effect on care delivery. The
focus group session was recorded and transcribed using word processing software.
Analysis of the focus group data was performed with Microsoft Excel. Responses were
labeled by participant and focus group question. Categories and corresponding codes were
assigned to each response. Categories were selected based on the sample outcomes of interest
under the acceptability and demand areas of focus outlined in the publication by (Bowen et al.,
2009). The sorting function was utilized to explore for common themes among the identified
categories. Additionally, possible future directions of the pathway were discussed. Data were
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then synthesized based on the identified themes and a synthesis table was created to report
specific highlights from the focus group.
To measure PCP self-efficacy, a questionnaire was adapted from a validated tool
published by Loeb et al. (2017) on mental illness management. Cronbach’s alpha coefficient for
reliability of the MIM was α = 0.88 and interpreted as “good” reliability. Construct validity of
the MIM was calculated using a Pearson correlation coefficient and was found to have a
statistically significant positive correlation (P <0.05). The MIM self-efficacy scale was
specifically designed for measuring PCP self-efficacy in the management of mental illnesses
(Loeb et al., 2017).
The modified MIM questionnaire used to assess PCP self-efficacy in the diagnosis and
treatment of adolescent depression and anxiety contains ten structured-response items and was
administered to the participating PCPs pre- and post-intervention. The PCP rated his or her
confidence in the ability to perform each task on a 10- point scale. The surveys were
administered electronically using the Qualtrics XM software. Changes from the pre- test and
post- test scores were recorded and mean scores for each survey item were calculated to assess
trends in PCP self- efficacy. (See Appendix F for the sample MIM questionnaire). Statistical
significance of the results was unable to be determined based on the small sample size (n = 7).
Ethical Considerations
Patient data were not collected as part of this study. To assure congruence with West
Virginia University’s research and ethical policies, a formal proposal was submitted to and
approved by the University’s Internal Review Board (IRB). Institutional support and approval
were also obtained through WVU Medicine’s Nursing Research Council internal review process.
Participation and use of the pathway by PCPs in the project was voluntary and as a quality
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improvement initiative, consent was assumed upon completion of the questionnaires and
participation in the focus group. No conflicts of interest have been identified and no vulnerable
populations were utilized in the study methods.
Results
After collecting the pre-intervention MIM questionnaire, the participating PCPs were
presented with the intervention and feasibility study process. The PCP Packet containing the
medication guide, the treatment algorithm, the BHC directory, and the EMR template list were
then provided to the participants. Data were not formally gathered over the course of the project
implementation period, but participants were asked to keep track of their own use of the pathway
by making note of their experiences and reactions to the intervention. Participants were also
asked to contact the project champion if any technical difficulties were experienced. Shortly after
implementation, several participants were unable to auto populate the BHC provider list patient
handout within the EMR. This was quickly corrected but decreased the timeframe that the
providers could use this function and may have altered its perceived usefulness.
Focus Group Results
Actual Use
Data collected from the focus group revealed frequent use of the pathway by all PCP
participants during the project timeframe. Most indicated that the pathway was referred to at
least weekly, but usually during daily practice. One participant indicated that not all components
of the pathway were used in the treatment of each patient and that certain components of the
pathway could be used independently. PCP participant responses included “I referred to the
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pathway usually daily, sometimes multiple times per day” and “I did not always have patients fit
all of the scenarios so I may have referred to different components of the pathway on a case-tocase basis.”
Varying numbers of adolescents presented with anxiety and depression during the project
implementation timeframe. Some PCP participants indicated that there were periods of time
where use of the pathway was not warranted. It was discussed that the duration of the
intervention may have been too short to see all the intended effects on care delivery.
Relevance to Practice
The focus group participants reached a consensus that use of the pathway is relevant to
the practice setting and useful in the management of adolescent depression and anxiety. The lack
of available and timely resources in the communities served was stated to be the primary reason
the pathway was considered relevant. Participants were most satisfied with the application of the
medication guide and the EMR visit templates. Additionally, the participants indicated that they
were also satisfied with the management algorithm and that specific types of therapies provided
was included in the BHC directory. All participants expressed that the pathway was relevant to
their respective practices.
The pathway was perceived to be the most useful when applied to straightforward
patients. The pathway was less useful for those with comorbidities or complex situations. One
participant stated, “The pathway was most useful when patients were more straightforward and
less useful when complex. Patients with comorbidities such as ADHD made the pathway harder
to follow.”
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Participants indicated that use of the pathway both increased the number of patients they
treated instead of referring to BHCs and increased comfortability in the management of
adolescent depression and anxiety. During the focus group, one PCP participant stated, “The
amount of patients I have seen, especially after COVID and even before COVID and with the
resources we do not have. It’s been helpful as I use it more and become more efficient. A lot of
my patients were stuck on waiting lists for psychiatry.” Another PCP participant replied,
“Patient parents were very thankful because normally I would just refer these patient's out, but
this allowed me to do a lot of management in office which was nice for them as they were
already comfortable and familiar with us.” The PCP participants indicated that use of the
pathway resulted in a shorter amount of time between diagnosis and treatment for many patients
diagnosed with depression and anxiety.
Impact on Practice
Participants expressed that the initial stages of the intervention period resulted in lower
productivity while acclimating to the pathway’s use. The pathway did not help with clinical
efficiency regarding visit length. However, most participants agreed that once acclimated to the
pathway there was no negative impact on visit length or clinical efficiency. Participants also
indicated that continued use of the pathway resulted in more ease of use. One participant stated,
“As with anything it slowed me down at first. I am not sure it has helped me manage these
patients more quickly, but it has made me feel more comfortable.”
Encountered Barriers
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Participants indicated dissatisfaction with the changing nature of the BHC directory.
Waiting list times vary naturally and were not periodically updated during the project period.
Despite only 12 weeks of the intervention timeframe, several other components of the BHC
directory changed including services offered, insurances accepted, and providers no longer
serving the area. These changes were especially challenging to determine for out of network
BHCs. Furthermore, waitlists for CAPs also increased to 8-12 months during the project as well,
forcing PCPs to manage more severe or complex presentations than they were comfortable with
in the interim. Additionally, the two CAPs in Harrison County quit accepting referrals due to the
abundance of waitlisted patients. The pathway was perceived as less useful to the participants for
patients with complex or severe presentations and for those with comorbid conditions.
Although the pathway was designed to increase collaboration with community BHCs,
especially those out of network, participants did not feel that the pathway guaranteed
collaboration. The main barrier to collaboration is time constraints for both PCPs and BHCs. The
directory did provide a more direct route of making contact or referrals to the BHCs but may not
have had the intended effect on PCP and BHC collaboration.
An unanticipated issue faced by several participants involved referring patients to receive
a certain type of evidence-based psychotherapy such as cognitive behavioral therapy, but later
learning that patients were receiving more traditional talk therapy. Patients often did not contact
the PCP participant between appointments to inform them of this issue, leading to a delay in
initiation of the intended treatment regimen.
Intent to Continue Use

24

Most PCP participants recommended use of the pathway for a longer period, followed by
another focus group session, before making any changes. Several participants expressed the
desire to use the pathway for a longer period of time to determine what changes may be needed.
All participants indicated the intention to continue using the pathway to guide applicable
treatment regimens. The determination was made to recycle the PDSA process and approach
organizational leadership for approval to expand the project to other practices and complete
further study of the intervention. (See Appendix G for the focus group response synthesis table).
MIM Questionnaire Results
Pre-intervention responses on the MIM questionnaire showed varying baseline levels of
self-efficacy in the treatment of adolescent depression and anxiety among the PCP participants.
The pre-intervention MIM scores indicated that participants were most comfortable with
diagnosing depression and anxiety in adolescents, classifying the severity of those diseases, and
having productive conversations about patients with psychologists and psychiatrists prior to the
intervention. The lowest pre-intervention scores were on the items related to treatment of
depression and anxiety in adolescents and in the treatment of patients who have both chronic
medical and mental diseases.
Post-intervention MIM scores indicate that the PCP participants experienced the most
improvement of self-efficacy in the treatment of adolescent depression and anxiety, the diagnosis
of adolescent anxiety, the classification of severity of adolescent anxiety, and the
recommendation of community resources for mental health disorders.
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Despite an increase in the mean scores of all survey items of the MIM questionnaire; two
participants scored their self-efficacy higher on several survey items on the pre-implementation
questionnaire compared to their post-implementation scores. Causes of these two outliers would
be worth exploring in a future study of this pathway.
Although statistical significance cannot be determined due to sample size (n = 7), the
mean scores of the MIM questionnaire items increased by an average of 1.05 points following
project implementation suggesting an improvement in PCP self-efficacy (Figure 1); thus,
meeting one of the project’s major aims.
Figure 1
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One participant that used the pathway was unavailable at the time of the focus group
session but completed the pre-intervention and post-intervention MIM questionnaire resulting in
some missing focus group data.
Summary
Feasibility of the project was determined based on the examined areas of acceptability
and demand (Bowen, et. al, 2009). Analysis of the focus group data revealed several common
themes. Based upon these themes and the overall discussion with the PCP participants, the
decision was made to continue use of the pathway, as written, for another 12-week period.
Determination to use the pathway as written was made because the PCP participants did not feel
that the project timeframe was long enough to recommend needed changes.
The initial PDSA cycle of the QI project met three of the project’s aims based on the data
collected. The aim to increase collaboration between the PCP participants and community BHCs
with shared patients was not achieved. Use of the pathway was favorable among PCP
participants and had the intended effect within the project context.
The pathway was successfully implemented into each PCP participant’s practice. Use
was reported from daily to weekly and was perceived as relevant to the intended pediatric
primary care setting. Participants were most satisfied with the medication guide, the treatment
algorithm, and the EMR visit templates provided within the PCP packet. The perceived impact
on practice involved initial slowing of clinical efficiency that resolved with persistent use.
Care delivery was perceived to be improved and increased for most participants
evidenced by the focus group discussion. Use of the pathway was determined to increase the
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number of adolescents with depression and anxiety managed by the participating PCPs. Prior to
project implementation, most patients with these conditions were referred, waitlisted to see a
CAP, or received no mental health care. This suggests that the time from diagnosis-to-treatment
decreased for adolescents with depression and anxiety during the project implementation period.
Number of patients reached pre-intervention and post-intervention was not measured during this
PDSA cycle.
Participants encountered barriers to collaboration with out of network community BHCs
mainly due to time constraints and changes to services provided by the BHCs during the project
implementation period. The BHC directory information changed during the project period further
contributing to underachievement of the project aim to increase collaboration with community
BHCs. Despite this, several participants reported satisfaction with using some portions of the
BHC directory. MIM questionnaire mean scores on items 9 and 10, relating to collaboration with
BHCs and CAPs, increased from pre-implementation to post-implementation.
MIM questionnaire results showed a positive trend in the means of each survey item
suggesting some improvement in provider self-efficacy. Some participants also indicated that use
of the pathway reduced their anxiety, decreased the amount of time spent looking up information
contained in the pathway, and increased provider comfort in the treatment of adolescent anxiety
and depression during the focus group session.
Interpretation
The determination of feasibility increases the likelihood that an intervention will be
effective on a larger scale (Bowen, et. al 2009). Further study of the intervention within the
project setting is rationalized based on the post-implementation findings of this QI initiative.
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The number of adolescents with depression and anxiety managed by the participating
PCPs was reported to have increased during the project implementation period. Although
statistical significance cannot be determined with such a small study cohort, the positive themes
and trends in study data and the determination of feasibility within the context of practice
suggests that the project had the intended effect on the identified practice problem and is
clinically significant. Additionally, the intervention was found to be relevant to the patient
population of interest according to the PCP participants.
Several components of ICMs/ CCMs determined to be effective in the publication by
Yonek et al. (2020) were incorporated into the clinical pathway and were implemented during
the project implementation period including measurement- based care, evidence-based mental
health services, psychiatric consultation, planned communication/ shared treatment plans, and
health information technology. PCP participants encountered the most barriers when utilizing the
BHC directory intended to increase collaboration with community BHCs and the utilization of
community resources. However, MIM questionnaire mean scores for items 7, 9, and 10 increased
following the intervention indicating some increase in PCP confidence with recommending
community resources for mental health disorders.
The findings of the MIM questionnaire are consistent with those found in the publication
by Asarnow et al. (2015) which concluded that provider decision making tools and formal
management protocols result in higher levels of PCP self-efficacy in the treatment of mental
health disorders. The MIM questionnaire items with the most increase in pre-intervention to
post-intervention self-efficacy scores were in the areas of the treatment of adolescent depression,
the diagnosis of adolescent anxiety, the treatment of adolescent anxiety, and the recommendation
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of community resources for mental health disorders. The larger increase from pre-intervention to
post-intervention scores on items 3 and 6 on the MIM questionnaire is a positive finding
considering that the clinical pathway was designed to aid in the treatment of adolescent
depression and anxiety.
Several themes emerged during the focus group leading to a discussion on future
directions of the project following another cycle of the PDSA quality improvement process.
Possible changes that will be revisited and considered include more formal networking with
community BHCs, determining a point person to regularly update the BHC directory, and
expanding the treatment algorithm to include specific measurement-based tools for diagnosis and
for follow up severity classification. Expansion of the project to include more PCPs and further
study of the intervention is warranted.
Limitations
This QI project has several limitations including a small sample size and a short
implementation timeframe. Feasibility studies have inherent limits on generalizability as they are
designed to be tested within specific contextual settings. Due to the feasibility study design,
control for external variables is not comprehensive. Confounding variables may include PCP
provider type, years in practice and in the current practice setting, variation in individual PCP
patient population demographics, experience in the management of mental health illness prior to
project implementation, provider personality and care delivery styles, and an inconsistent
number of patients presenting with anxiety and depression between participants during the
implementation period. The results of this study are limited to the determination that the
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intervention was successfully implemented and is relevant to and feasible within the project
setting.
Conclusions
The intervention was determined to be feasible within the practice setting which warrants
further testing within the organization to evaluate the effectiveness and to justify expanded
implementation in other primary care offices across the health system. Following another 12week cycle of the intervention, all participants have agreed to complete a second focus group to
determine formal recommendations on the future directions of the project. Institutional approval
to expand the project and complete further study of the intervention will then be sought by
presenting the findings to institutional leadership.
In future iterations, emphasis should be placed on the barriers encountered while using
the BHC directory within the clinical decision-making pathway to increase collaborative care
with community BHCs. Mitigation of these barriers may be possible through more frequent
directory updates and more frequent contact between the PCPs and BHCs. Collaboration may
still be hindered by provider time constraints. Further integration of care in this healthcare setting
should be considered within the organization. The primary barrier to further integration includes
costs associated with reallocating or expanding current resources or hiring more personnel which
may be dependent on organizational and departmental budget and leadership approval. Available
funding through state and federal grants may also be explored for expansion of the project in the
future.
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Two PCP participants had lower post-intervention scores than pre-intervention scores on
many MIM questionnaire items which was an interesting finding. In future PDSA cycles, postimplementation MIM scores should be collected and analyzed before the focus group session
allowing for further explanation of the responses. Focus group questions should also include
discussion of perceived provider self-efficacy, which could be compared to MIM questionnaire
data.
The clinical decision-making pathway could be utilized in other primary care practice
settings including family and internal medicine practices that care for pediatric patients assuming
customization of the BHC directory to the practice community setting. The project may also be
expanded to include management of depression and anxiety in younger pediatric patients if
adjustments are made to the medication guide to include age of approvals for the included
psychotherapeutic drugs.
In conclusion, incorporating elements of ICMs/CCMs in primary care can help decrease
diagnosis-to-service gaps in adolescents with depression and anxiety. With the ongoing shortage
of CAPs and the increasing mental health crisis, the medical community must become creative in
care delivery. CCMs and related interventions have the potential to facilitate interprofessional
collaboration and improve the likelihood that affected adolescents will receive evidence- based
mental health services. Utilization of this collaborative care, decision making pathway in the
primary care setting has the potential to improve and expand mental health services provided to
adolescents with anxiety and depression.
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Appendix A
Literature Search Matrix with PICO(T) Question
PICO(T)
Population: adolescents with diagnosed depression, anxiety, or both
Intervention: development and implementation of a clinical pathway involving a collaborative care model
Comparison: usual care
Outcome: increase provider self-efficacy in treatment

Date
2/27/21

Search Term
Treatment Models
adolescent depression

Hits
283

2/28/21

Database
CINHAL
with full
text
CINHAL

Depression treatment
adolescent OR
teenager protocol
primary care

1197

3/1/2021

Pubmed

(((((((((adolescent)
OR (teen)) AND
(primary care)) OR
(pediatric)) AND
(depression)) OR
(dysthymia)) OR

99,626

limits
Notes
2015-2021 32 abstracts reviewed. 2 critically appraised, but need to
broaden terms, not many relevant articles for treatment.
Add protocols.
2016-2021 Mind-Body Skills Groups
for Adolescents with Depression in Primary Care: A Pilot
Study. (n=43) (reviewed reference list)
The natural course of depression treatment of adolescent
depression: issue with adherence to treatment
Article from the American journal of Child and Adolescent
Psychiatry cites the relevance of my topic. Website
redirected to the Center for Integrated Health Solutions
2016-2021 Many are not specific to adolescent population.
RCT
Narrow terms
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3/5/2021

Pubmed

3/7/21

Pubmed

3/9/21

Search all
in libraries

3/9/21

CINHAL
with Full
text

(mood)) AND
(treatment)) OR
(intervention)) OR
(medication)
(((((((((((((adolescent) 3656
OR (teen)) OR
(adolescence)) OR
(teenager)) AND
(Pediatric)) AND
(Depression)) OR
(dysthymia)) OR
(mood)) AND
(treatment)) OR
(intervention)) OR
(protocol)) OR
(model)) AND (brief
behavioral therapy))
OR (modification)
brief behavioral
1986
therapy for pediatric
OR adolescent OR
teen AND depression
Zukerbrot et al
58

Adolescent OR teen
87
OR youth OR
teenager AND
Depression OR Major
Depressive Disorder
OR MDD OR

Same as
above
adding
systematic
reviews

50 abstracts reviewed: 5 articles critically appraised. Need
to narrow down terms

2016-2021 Reviewed 26 abstracts, no articles met inclusion due to
lower levels of evidence
Last 10
years

Used to find publications mentioned in guideline of lead
author/ referenced in the guideline
1 article for critical appraisal relevant to focus in addition to
article in search. Saved to Zotero
2016-2021 Duplicates excluded. Modify terms. 5 articles saved to
Zotero for later abstract review.
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Depressive AND
Integrated Care
adolescents or
47
teenagers or young
adults or teen or
youth AND
depression or
depressive disorder or
depressive symptoms
or major depressive
disorder AND
integrated care or
integrated approach
or integrated model
AND primary care

3/10/21

3/11/21

Google
scholar

integrated mental
health care pediatrics

3/18/21

All
databases

Used cited sources to
find a mentioned SR

3/19/21

Google
scholar

Pediatric behavioral
health integrated
model

16,7000

none

10 abstracts reviewed: (including the 5 from the previous
search)
Utilization of integrated and collocated BHC models in
peds primary care: critically appraised

2017-2021 Key Components of Effective Pediatric Integrated Mental
Health Care Models: A systematic review (2020)
Five-year outcomes of behavioral health integration in
pediatric primary care (study through Boston children’s).
Both studies met inclusion: critically appraised using tools
in Melnyk-Overholt & Fineout text.
2015-2021 Found article: cited by many of sources found so far.
Arsanow et al. (2015). Saved to Zotero for consideration of
inclusion
2015-2021 Found a SR from 2019 comparing outcomes/ symptom
improvement with use of a BHIP
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4/10/21

4/15/21

5/25/21

5/26/21

Cross
search on
Ebscohost:
APA
psychline,
APA
Psych info
and Psych
articles,
Medline,
CINHAL
with full
text
NIH
search

Pediatric depression
in primary care

1940

none

Brief report on likelihood to refer to psych (discusses
provider’s feeling poorly prepared to treat pediatric
depression, but higher comfort with ADHD)

Prevalence of
adolescent depression
and access to care

Several,
selected
data
reports
only

none

(National Institute of Mental Health, 2019)
(Ghandour et al., 2019)
Use for intro/ problem statement (data from 2016-2017
most recent reported according to sources)

Cross
search
APA
psychline,
APA
Psych info
and Psych
articles,
Medline,
CINHAL
with full
text
CINHAL
with Full
text

Prevalence of
adolescent depression
and anxiety

Last 5
years, US,
English

20 abstracts reviewed
6/3 23 abstracts reviewed (total 156)

Clinical practice
guidelines anxiety
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6/9/21

Google

Implementing
Integrated Care in a
hospital system

Over 32
million

None

SAMHSA website referred to Center for Excellence in
Integrated Health Solutions: Level of Integration
Framework
Readiness questionnaire: lead to
Satcher & Rachel, 2016: Increasing health equity using
integrated care (vulnerable populations, underserved areas)
CDC data retrieved for problem statement

6/24/21

Academic
Search
Complete

combination therapy
for anxiety in
adolescents

164

none

Brown University publication Child
& Adolescent Psychopharmacology Update noted findings
from largest RCT comparing treatment modalities called
Child-Adolescent Anxiety Multimodal Study (search for
and possibly use) reviewed abstract

7/6/21

Google

Validated tool
provider self-efficacy

None

Use and modify Mental Illness Management (MIM) to use
to evaluate provider self-efficacy at baseline and following
the project timeframe.
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Appendix B
Literature Review Synthesis
Design

Sample

Intervention
(Integrated model
type)/Controls

Outcome

Conclusions

A CPG

Children
aged 10-21

-

Recommendations include integrated care for
assistance with diagnosing and education programs/
practice readiness for treating adolescents with
depression

B CPG

Children
aged 10-21

-

Recommends use of integrated care/ combination
therapy by severity type. Acknowledges the need for
more access to care/ relevance of an ICM

C CPG

Children
and
Adolescents

-

Recommends use of combination therapy: more
effective than those interventions alone. Use of
Integrated care is a method that could overcome
barriers to treatment initiation and adherence. This
guideline only briefly mentions integrated care and
terms it “care coordination”.

Provider training and
either independent
management by the PCP or
integrated model. No
standard definition of
ICMs. Recommended
collaborative care/
establishing relationships
with community BHCs
Provider training and
either independent
management by the PCP or
integrated model (does not
specify type of model):
used as a general term
“Successful treatment is a
collaborative care effort”
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D MA

N=31 RTCs

Examined studies
comparing ICM’s to
usual care or
enhanced usual care

For each of the 31 studies the primary outcome was
used to measure effect size. Several trials utilized
some form of ICM in some form. Overall summary
effect was found to have a small and statistically
significant effect (d=0.32; 95%CI, 0.210.44;P<0.001)

E SR

N=6 studies

Increased access to care, fewer depressive symptoms,
longer duration of treatment with ICM or BHIP than
in control groups with all evaluated studies

F EBQI
study

N=105
PCPs

Reviewed studies
evaluating
collaborative or
integrated care
models for children
aged 0-21 years with
BH disorder
compared to usual
care
4 phase BHIP
(Behavioral Health
Integration Program)
1. BH ed.
2. Psych consults
3. Tech and clin.
Support for
PCPs
4. On site BH
service

Literature review of
RCTs measuring

Model used varied across studies. Table present to
define models used.

G SR

N=2190
total







Increased integrative care (P<0.001)
Psychotherapy (P<0.001)
Medical BH visits increased (P=0.4)
Costs of ambulatory and outpatient costs
increased, but BH-related ER visit cost decreased
by 19%
Provider satisfaction and self-efficacy: rated as
high and 93% of participating PCPs believed that
BHIP participation enabled them to appropriately
care for effective management of mild and
moderate BH problems in pediatric primary care

ICM focused on treatment
vs. preventative showed to
be more effective in this
MA. ICM of some form,
including PCP training,
collaborative support/
consultation, referral
system, and management
algorithm. More research
in pediatrics is needed.
Relationship with BHC
and PCP. Researchers
recommend some form of
psychotherapy and
medication algorithm to
increase PCP comfort in
the management of BH
disorders
Use of the BHIP increased
provider self-efficacy.
Concluded that this
increases care delivery,
treatment completion, and
increases access to mental
health care (More people
treated in the BHIP group).
Potential for visit cost
savings

BHC for psychotherapy
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participants,
11 RTCs
age:<18 yr

patient outcomes for
BH disorders
(depression, ADHD,
other behavioral
disorders)








7/11 reported a positive correlation between the
intervention and outcomes and of those the most
common models included population-based care,
measurement-based care, and evidenced based
mental health services. (5 of these utilized combo
therapy within the ICM)
2/11 reported a positive correlation between
intervention and functional impairment
2/11: positive correlation between intervention
and mental and physical quality of life
4/11 reported pos. correlation between
intervention and patient satisfaction with
treatment
All studies incorporated some degree of
population-based care, measurement-based care,
evidence based mental health services, treatment
to target, and care management

PCP training and
prescribing of
psychotherapeutic
medications
Practices/ organizations
can pick components that
best suit patient
demographics and
community resources.

A- (Zuckerbrot et al., 2018) B- (Cheung et al., 2018) C- (Walter et al., 2020) D- (Asarnow et al., 2015) E- (Burkhart et al., 2020) F(Walter et al., 2019) G- (Yonek et al., 2020)
CPG- Clinical practice guideline, MA- Metanalysis, SR- Systematic review, EBQI- Evidence-based quality improvement, PCP- Primary
care provider, ICM- Integrated Care Model, BHC-Behavioral health clinician, BHIP- Behavioral Health Integration Program, BHBehavioral Health, RCT- Randomized controlled trial
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Appendix C
SAMSHA/ HRSA Coordinated Integrated Care Framework

Coordinated Integrated Care: SAMSHA/ HRSA Six Levels of Collaboration/ Integration (Project Benchmark)
Level 1: Minimal Collaboration: Current state of practice
Level 2: Basic Collaboration at a Distance: Goal behaviors
Physical Proximity: PCP and BHCs in separate facilities














Have separate systems
Communicate about cases only rarely and under
compelling circumstances
Communicate, driven by provider need
May never meet in person
Have limited Understanding of each other’s roles







Have separate systems
Communicate periodically about shared patients
Communicate, driven by specific patient issues
May meet as part of larger community
Appreciate each other’s roles as resources

Clinical Delivery
Screening and assessment done according to separate
 Screening based on separate practices: information may
practice models
be shared through formal requests or Health Information
Exchanges
Separate treatment plans
 Separate treatment plans shared based on established
Evidence-based practices (EBP) Implemented separately
relationships between specific providers
 Separate responsibility for care/ EBPs
Patient Experience
Patient physical and behavioral health needs are treated
 Patient health needs are treated separately, but records
as separate issues
are shared, promoting better provider knowledge
Patient must negotiate separate practices and sites on
 Patients may be referred, but a variety of barriers prevent
their won with varying degrees of success
many patients from accessing care
Practice/ Organization
No coordination or management of collaborative efforts
 Some practice leadership in more systematic information
sharing
Little providers buy-in to integration or even
collaboration, up to individual providers to initiate as
 Some provider buy-into collaboration and value placed
time and practice limits allow
on having needed information
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Business Model
Separate funding
 Separate funding
No sharing of resources
 No sharing of resources
Separate billing practices
 Separate billing practices
Advantages
Each practice can make timely and autonomous decision
 Maintains each practice’s basic operating structure, so
about care
change is not a disruptive factor
Readily understood as a practice model by patients and
 Provides some coordination and information-sharing that
providers
is helpful to both patients and providers
Disadvantages
Services may overlap, be duplicated, or even work
 Sharing of information may not be systematic enough to
against each other
effect overall patient care (More research is needed)
Important aspects of care may not be addressed or take a
 No guarantee that information will change plan or
long time to be diagnosed
strategy of each provider
 Referrals may fail due to barriers, leading to patient and
provider frustration

Adapted from The Center for Integrated Health Solutions, (n.d.) CIHS’ Standard Framework for Levels of Integrated Healthcare.
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Appendix D
Clinical Decision-Making Pathway for the Treatment of Adolescent Depression and Anxiety
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Anxiety and Depression Decision-Making Treatment Algorithm
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Psychopharmacotherapy Medication Guide
Anxiety and Depression in Children and Adolescents
1st line choices: Serotonin Reuptake Inhibitors (SSRIs)
Medication
Generic/ Brand

Formulations

Age

Starting Dose

Titration
Amount/Schedule

Effective/ Max
Dose

Fluoxetine/ Prozac

Liquid: 20mg/5ml
Tabs: 30mg 60mg
Caps: 10mg, 20mg,
40mg
Liquid: 1mg/ml
Tabs: 5mg, 10mg, 20mg
Liquid: 20mg/ml
Tabs: 25mg, 50mg, 100g
Liquid: 10mg/5ml
Tabs: 10mg, 20mg, 40mg

> 8 years

10mg

10-20mg

20mg/ 60mg

> 12 years

10mg

5mg

10mg/20mg

> 6years

25mg

12.5-25mg

50mg/200mg

>12 years

10mg

10mg

20mg/ 60mg

Escitalopram/Lexapro
Sertraline/ Zoloft
Citalopram/Celexa
E
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BHC Directory Template
Practice

Practice/
Facility Name

Age
Offer Provider Specifics
Group s CBT
Serve
d
Yes/
BHC provider names and credentials
No
BHC provider certifications and
specialty therapy training

Additional Information







Services provided
Website if available
Designation of
specific populations
served such as
LGBTQ friendly
Option for telehealth
services

Contact

Physical Address:
Phone:
Fax:
Provider Email:
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Template Smart Phrases for Clinical Use

Visit Templates

Pt Education

.pedsanxietyinitial
.pedsanxietyfollowup
.pedsdepressioninitial
.pedsdepressionfollowup
.ssriinitialeducation
.pedsanxietyed
.pedsdepressioned
.therapyoptionslist
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Appendix E
Focus Group Questions

1. What about the use of the clinical pathway are you the most satisfied or dissatisfied with?
2. Did you refer to the clinical pathway to guide your clinical decision making in the treatment of adolescent depression
and/or anxiety? If so, how often?
3. Give an example, of a situation when the clinical pathway was very useful in a patient’s plan. What about an example
of when it was not useful?
4. If you used the clinical pathway, what portion or portions of the clinical pathway did you used the most during the
project period.
5. Were there any aspects of the clinical pathway you did not use or do not feel were relevant to the project?
6. What did you find the most challenging about using the clinical pathway?
7. Describe what impact that using the clinical pathway had on your day-to-day clinical practice.
8. Did you find this project to be appropriate to the patient population you regularly work with? Why or why not?
9. Do you intend to continue to use the clinical pathway follow the project timeframe? Why or why not?
10. Are there any suggestions for changes to the pathway for future use in your practice setting?
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Appendix F
Modified MIM Questionnaire
Adapted from Loeb et al., (2017)
How confident are you that you can:
1) Diagnose major depressive disorders adolescents?
2) Classify severity of major depressive disorders in adolescents?
3) Treat major depressive disorders in adolescents?
4) Diagnose generalized anxiety disorder in adolescents?
5) Classify severity of generalized anxiety disorder in adolescents?
6) Treat generalized anxiety disorder in adolescents?
7) Recommend community resources for mental health disorders?
8) Treat your patients who have both chronic medical and mental illness?
9) Have a productive conversation with a psychologist to care for a patient with a mental health disorder?
10) Have a productive conversation with a psychiatrist to care for a patient with a mental health disorder?
Not at all confident

1

2

3

4

5

6

7

8

9

10

Extremely confident
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Appendix G
Focus Group Response Synthesis
Outcomes of Themes
Interest/
Category
Actual use
Use of the pathway was daily to several
times weekly across all participants.
Use of all pathway components was not
always needed for each patient and the
pathway components could be used
independently.
Duration of the intervention may not have
been long enough to see all intended effects
due to variable amounts of teenage patients
presenting with anxiety and depression.

Relevant Quotations
“I referred to the pathway usually daily, sometimes multiple
times per day.”
“I did not always have patients fit all of the scenarios so I may
have referred to different components of the pathway on a
case-to-case basis.”
“It would be useful to continue before we make any changes.
Patients are coming in clusters so more time will help for
consistency.”
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Relevance to
practice

The project was perceived to be relevant to
the practice setting especially due to the lack
of available and timely resources in the
communities in which the PCPs serve.
The pathway was most useful with
straightforward patient cases. Those with
more complex conditions it was less useful.
The medication guide and the algorithm
were perceived to be the most utilized
components of the pathway.
Several participants indicated that it
increased the number of patients treated
verses referred and waitlisted in his or her
own practice.

“The pathway was definitely appropriate. Teenagers and
preteens are everywhere, this is a problem they have. It is
sometimes hard separating day-to-day anxiety or situational
anxiety verses disorders, but with the lack of resources we
have, it is particularly important. It is not like you can just
send them somewhere if they need medications and have
them seen in a few weeks.”
“The pathway was most useful when patients were more
straightforward and less useful when complex. Patients with
comorbidities such as ADHD made the pathway harder to
follow.”
“It removed a lot of stress for me by keeping me focused and
help guide me when I would have spent a ton of time just
doing research and looking up options for each patient.”
“The amount of patients I have seen, especially after COVID
and even before COVID and with the resources we do not
have. It’s been helpful as I use it more and become more
efficient. A lot of my patients were stuck on waiting lists for
psychiatry.”
“Patient parents were very thankful because normally I would
just refer these patient's out, but this allowed me to do a lot of
management in office which was nice for them as they were
already comfortable and familiar with us”
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Impact on
practice

Slowing of clinical practice in the beginning
of using the pathway.
Using the pathway for a longer period may
be indicated to determine the true impact on
practice.

“As with anything it slowed me down at first. I am not sure it
has helped me manage these patients more quickly, but it has
made me feel more comfortable.”
“A longer time frame would help with efficiency, but I am
still not completely used to using it so it is more difficult to
tell.”

Ease of use improved with continued use for
some PCP participants.
Encountered
barriers

Resources in the community remain
insufficient. The directory providing
information, which was useful, but providers
still had difficulty getting patients into
evidence-based psychotherapies.

“The BHC directory provides a list but does not guarantee
counselor or CAP availability. Some therapists are listed to
provide CBT but are not actually providing it.”
“The ever-changing BHC directory based on provider
availability or changes in the community”

The BHC directory changed during the
project timeframe. Wait list times changed
and availability of services changed
complicating use of the directory.
The BHC directory did not seem to increase
the amount of collaboration between PCPs
and BHCs to the degree it was intended.
Intent to
continue use

All participants indicated that they planned
to continue use of the clinical pathway.

“I definitely plan to continue use”
“I need to use it for a longer period of time before
determining changes”

